Trial · NCT00537290
Adverse events44
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 44
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Chest pain with fever, chills, and low back pain | Cardiac disorders | Rituximab | 1 | 19 | 2 |
| other | Transient chest pressure | Cardiac disorders | Rituximab | 3 | 19 | 3 |
| other | Diffuse severe erythematous rash | Skin and subcutaneous tissue disorders | Rituximab | 1 | 19 | 1 |
| other | Facial rash | Skin and subcutaneous tissue disorders | Rituximab | 1 | 19 | 1 |
| other | Nausea | Gastrointestinal disorders | Rituximab | 1 | 19 | 1 |
| other | Transient palpitations (recurrence) | Cardiac disorders | Rituximab | 1 | 19 | 1 |
| other | Deep vein thrombosis (recurrence) | Vascular disorders | Rituximab | 1 | 19 | 1 |
| other | Raynaud's phenomenon (new) | Vascular disorders | Rituximab | 1 | 19 | 1 |
| other | Rash (diffuse) within 1 week of rituximab infusion (new) | Skin and subcutaneous tissue disorders | Rituximab | 1 | 19 | 1 |
| other | Rash (local) within 1 week of rituximab infusion (new) | Skin and subcutaneous tissue disorders | Rituximab | 1 | 19 | 1 |
| other | Rash (local) due to nail glue allergy (new) | Skin and subcutaneous tissue disorders | Rituximab | 1 | 19 | 1 |
| other | Gastrointestinal reflux disease (new) | Gastrointestinal disorders | Rituximab | 1 | 19 | 1 |
| other | Epistaxis (recurrence) | Blood and lymphatic system disorders | Rituximab | 1 | 19 | 1 |
| other | Upper respiratory tract infection | Infections and infestations | Rituximab | 6 | 19 | 6 |
| other | Tonsillitis, otitis, sinusitis | Infections and infestations | Rituximab | 3 | 19 | 3 |
| other | Urinary tract infection | Infections and infestations | Rituximab | 3 | 19 | 3 |
| other | Bronchitis | Infections and infestations | Rituximab | 2 | 19 | 2 |
| other | Acute gastroenteritis | Infections and infestations | Rituximab | 2 | 19 | 2 |
| other | Cellulitis | Infections and infestations | Rituximab | 1 | 19 | 1 |
| other | Herpes zoster infection within 2 weeks of rituximab infusion (new) | Infections and infestations | Rituximab | 1 | 19 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00537290/events